Knights of Columbus Asset Advisors LLC
Position in KYMR — Kymera Therapeutics, Inc.
CIK 1688666
NEW HAVEN, CT
Position in KYMR
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$1,321,978
+$319,008 QoQ
Shares Held
15,872
+23.1% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in KYMR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Knights of Columbus Asset Advisors LLC holds $22,508,527 across 17 Biotechnology names. KYMR ranks #7 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AXSM |
Axsome Therapeutics, Inc.
|
19,677 | $3,325,806 | |
| 2 | MIRM |
Mirum Pharmaceuticals, Inc.
|
23,824 | $2,200,861 | |
| 3 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
3,707 | $1,940,503 | |
| 4 | CGON |
CG Oncology, Inc.
|
23,200 | $1,570,176 | |
| 5 | COGT |
Cogent Biosciences, Inc.
|
39,039 | $1,502,611 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
15,589 | $1,355,775 | |
| 7 | KYMR |
Kymera Therapeutics, Inc.
This page
|
15,872 | $1,321,978 | |
| 8 | IDYA |
IDEAYA Biosciences, Inc.
|
39,530 | $1,317,139 |
All Filings in KYMR
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,321,978 | 15,872 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,002,970 | 12,890 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $1,069,230 | 18,891 | Shares | Sole | 2025-11-03 | |
| No filing history on record for this holder in this stock. | ||||||